Investigations
Unilever plc
Unilever plc (UL) Failed to Disclose its Resolution to End Sales of its Ice Cream in “Occupied Palestinian Territory” and the Risks Associated with the Board’s Decision A class action
June 16, 2022
Investigations
Search
Categories
Archives
Investment Monitoring From Robbins LLP
To ensure your financial investments are being managed honestly, enroll in Stock Watch, our free investment monitoring service for individual and institutional investors.
Investigations
Verrica Pharmaceuticals, Inc.
Verrica Pharmaceuticals, Inc. (VRCA) Received a Complete Response Letter from the FDA relating to its New Drug Application for VP-102 A shareholder filed a class action on behalf of all
June 14, 2022
Investigations
Teladoc Health, Inc.
Teladoc Health, Inc. Misses First Quarter Financial Estimates Due to $6.6 Billion Non-Cash Goodwill Impairment Charge to Increased Competition A shareholder filed a class action on behalf of all
June 14, 2022
Investigations
IonQ, Inc.
IonQ, Inc. (IONQ) Failed to Disclose Material Information about the Development and Effectiveness of its Computers to Shareholders A shareholder filed a class action on behalf of all persons and
June 14, 2022
Investigations
Apyx Medical Corporation
Apyx Medical Corporation (APYX) Used its Products for Off-Label Indications A shareholder filed a class action on behalf of all persons or entities that purchased or otherwise acquired Apyx Medical
June 14, 2022
Investigations
Verrica Pharmaceuticals, Inc.
Verrica Pharmaceuticals, Inc. (VRCA) Received a Complete Response Letter from the FDA relating to its New Drug Application for VP-102 A shareholder filed a class action on behalf of all
June 10, 2022
Investigations
Investigation of CareDx, Inc.
CareDx, Inc. (CDNA) is Being Investigated by Multiple Government Agencies for Improper and Illegal Schemes Designed to Inflate Revenue A shareholder filed a class action on behalf of all
June 10, 2022
Investigations
LMP Automotive Holdings, Inc.
LMP Automotive Holdings, Inc. (LMPX) Has Material Weaknesses in Internal Control Over Financial Reporting A shareholder filed a class action on behalf of all persons and entities that purchased or
June 10, 2022
Investigations
Spero Therapeutics, Inc.
Spero Therapeutics, Inc. (SPRO) Failed to Obtain FDA Approval of One of its Lead Product Candidates A shareholder filed a class action on behalf of all persons and entities
June 10, 2022
Protect your